Ophthalmology Times Europe E-News:
Having trouble viewing this e-mail? Click here. 		You are subscribed to Ophthalmology Times Europe.
Click here to unsubscribe.
Ophthalmology Times Europe E-News
Modern Medicine Network
 
 
 
 
In this issue
• Ophthalmology Futures Forum 2013
• Optegra uses LensAR
• RNIB requires patients for research
• Chronic MH on OCT
 
 
Survey

Would you use bevacizumab and rapamycin after PRK?

Yes
0%
No
100%

You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Felicity Thomas, editor.
December 12, 2012
Save the date: Ophthalmology Futures European Forum 2013
The Ophthalmology Futures European Forum will be held on 3rd October 2013 in Amsterdam, The Netherlands. More...
Optegra first to use cataract laser in UK
Optegra is the first to offer the LensAR cataract laser in its London eye hospital. More...
RNIB requires wet AMD patients for research
The Royal National Institute of the Blind (RNIB) require 300 patients and carers to participate in two research projects. More...
Chronic MH has distinct features on OCT
Chronic macula holes (MHs) have distinct features compared to those of acute symptomatic MH on OCT findings. More...